@article{96672e9e55e749deb94be66561fb07f1,
title = "Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial",
keywords = "Antibodies, Monoclonal, Murine-Derived, Antirheumatic Agents, B-Cell Activating Factor, Double-Blind Method, Enzyme-Linked Immunosorbent Assay, Humans, Sjogren's Syndrome, Tumor Necrosis Factor Ligand Superfamily Member 13",
author = "Pollard, {Rodney P E} and Abdulahad, {Wayel H} and Arjan Vissink and Nishath Hamza and Burgerhof, {Johannes G M} and Meijer, {Jiska M} and Annie Visser and Huitema, {Minke G} and Spijkervet, {Fred K L} and Kallenberg, {Cees G M} and Hendrika Bootsma and Kroese, {Frans G M}",
year = "2013",
month = jan,
doi = "10.1136/annrheumdis-2012-202071",
language = "English",
volume = "72",
pages = "146--8",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ PUBLISHING GROUP",
number = "1",
}